Antirheumatic composition
AssigneeSeikagaku Kogyo Kabushiki Kaisha
InventorsShigehisa Aoki, Shinichi Iwasaki, Nobuo Sugiura, Sakaru Suzuki, Koji Kimata
Life of this patent
Estimating the term…
Abstract
This invention provides an antirheumatic composition which comprises a lipid-bound glycosaminoglycan or a salt thereof as an active ingredient and a pharmaceutically acceptable carrier and has an effect to inhibit extension of pannus.
Claims9
A method of treating rheumatism which comprises administering to mammals suffering from rheumatism a composition comprising between 0.1 to 80% lipid-bound glycosaminoglycan (gag) or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier, wherein said composition is administered in a dose of 0.1 to 2,000 mg/adult once a day or within several weeks.
Dependencies are inferred from the claim text.